Polywka S, Schröter M, Feucht H H, Zöllner B, Laufs R
J Clin Microbiol. 2001 Apr;39(4):1665-8. doi: 10.1128/JCM.39.4.1665-1668.2001.
Sera from 2,148 patients were tested with a third-generation microparticle enzyme immunoassay (MEIA), a confirmatory assay, and a reverse transcription-PCR. Overall, 85.6% of reactivities were confirmed, 13.2% were shown to be unspecifically reactive, and 1.2% were indeterminate. The rate of confirmed MEIA reactivities clearly depended on the strength of the reactivity.
对2148名患者的血清进行了第三代微粒体酶免疫测定(MEIA)、确证测定和逆转录聚合酶链反应检测。总体而言,85.6%的反应性得到确证,13.2%显示为非特异性反应,1.2%为不确定反应。MEIA确证反应性的比率明显取决于反应性的强度。